Treatment with loop diuretics, PDE-5 inhibitors, anticoagulants, bronchodilators, oxygen therapy, and antibiotics improved the condition of a 55-year-old female with cor pulmonale.
Case Report (n=1)
A case report demonstrating successful management of cor pulmonale secondary to COPD and pulmonary hypertension using a combination of diuretics, PDE5 inhibitors, and supportive therapies.
Cor pulmonale is a condition in which an alteration in the function and structure of the right ventricle of heart occurs, primarily as a result of respiratory disease which leads to increased blood flow resistance in the pulmonary circulation. Pulmonary hypertension is considered to be the most common link between lungs and heart dysfunction. Chronic obstructive airway disease is a common risk factor for the development of Pulmonary artery hypertension. The management requires focus on the underlying disease condition and treatment of the complications associated with Cor Pulmonale. Here the patient was a 55 year old female patient, presented with symptoms of Cor Pulmonale with a history of COPD and a recent case of severe pulmonary artery hypertension. She had anasarca and elevated BNP which indicated the right ventricle failure of heart associated with Cor pulmonale. The treatment included Loop diuretics, PDE 5 Inhibitors, Anticoagulants, Bronchodilators, Oxygen therapy and Antibiotics. The condition of the patient improved and hence was discharged.
Haris et al. (Tue,) conducted a case report in Cor pulmonale (n=1). Loop diuretics, PDE 5 Inhibitors, Anticoagulants, Bronchodilators, Oxygen therapy and Antibiotics was evaluated on Clinical improvement and discharge. Treatment with loop diuretics, PDE-5 inhibitors, anticoagulants, bronchodilators, oxygen therapy, and antibiotics improved the condition of a 55-year-old female with cor pulmonale.